|
Vitamin E: molecular and biological function
|
09 October 2019 |
|
Somatostatin-receptor imaging of medullary thyroid carcinoma
|
01 October 2019 |
|
The role of somatostatin and its analogs in the diagnosis and treatment of tumors
|
29 September 2019 |
|
Degradation of the neuropeptide somatostatin by cultivated neuronal and glial cells
|
29 September 2019 |
|
Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon alpha-2b and octreotide
|
27 September 2019 |
|
SSTR2A is the dominant somatostatin receptor subtype expressed by inflammatory cells, is widely expressed and directly regulates T cell IFN-gamma release
|
26 September 2019 |
|
Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications
|
25 September 2019 |
|
Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue
|
23 September 2019 |
|
Somatostatin receptor scintigraphy and therapy of neuroendocrine (APUD) tumors of the head and neck
|
20 September 2019 |
|
Plasma vitamin E and beta-carotene concentrations during radiochemotherapy preceding bone marrow transplantation
|
05 September 2019 |